These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21501227)

  • 1. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.
    Kolouchova G; Brcakova E; Hirsova P; Sispera L; Tomsik P; Cermanova J; Hyspler R; Slanarova M; Fuksa L; Lotkova H; Micuda S
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1544-51. PubMed ID: 21501227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats.
    Kolouchova G; Brcakova E; Hirsova P; Cermanova J; Fuksa L; Mokry J; Nachtigal P; Lastuvkova H; Micuda S
    Life Sci; 2011 Nov; 89(19-20):717-24. PubMed ID: 21925516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
    Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
    Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in renal glutathione in cholestatic liver disease is due to a direct effect of bile acids.
    Purucker E; Marschall HU; Geier A; Gartung C; Matern S
    Am J Physiol Renal Physiol; 2002 Dec; 283(6):F1281-9. PubMed ID: 12388394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats.
    Vos TA; Ros JE; Havinga R; Moshage H; Kuipers F; Jansen PL; Müller M
    Hepatology; 1999 Jun; 29(6):1833-9. PubMed ID: 10347127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
    Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
    Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
    El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
    Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.
    Dolezelova E; Prasnicka A; Cermanova J; Carazo A; Hyrsova L; Hroch M; Mokry J; Adamcova M; Mrkvicova A; Pavek P; Micuda S
    World J Gastroenterol; 2017 Nov; 23(43):7678-7692. PubMed ID: 29209109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver.
    Rodríguez-Ortigosa CM; Celay J; Olivas I; Juanarena N; Arcelus S; Uriarte I; Marín JJ; Avila MA; Medina JF; Prieto J
    Gastroenterology; 2014 Nov; 147(5):1084-93. PubMed ID: 25066374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice.
    Méndez-González J; Süren-Castillo S; Calpe-Berdiel L; Rotllan N; Vázquez-Carrera M; Escolà-Gil JC; Blanco-Vaca F
    Br J Nutr; 2010 Jan; 103(2):153-60. PubMed ID: 19822032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
    Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
    Wang L; Wu G; Wu F; Jiang N; Lin Y
    J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats.
    Hooiveld GJ; Vos TA; Scheffer GL; Van Goor H; Koning H; Bloks V; Loot AE; Meijer DK; Jansen PL; Kuipers F; Müller M
    Gastroenterology; 1999 Sep; 117(3):678-87. PubMed ID: 10464145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statins on cholestasis: good, bad or indifferent?
    Kuver R
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1467-9. PubMed ID: 21950741
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration.
    Kossor DC; Meunier PC; Handler JA; Sozio RS; Goldstein RS
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):108-14. PubMed ID: 8470113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.